![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
September 20, 2006
Follow-On Biologics
(Drug Wonks)
In his entry, blogger Peter Pitts discusses the need for FDA guidance on generic
or follow-on biologics, which Rep. Henry Waxman (D-Calif.) plans to address
by introducing legislation. "Yes, the FDA must set the standard
and sooner rather than later but should legislation trump science? Should
soundbites triumph over safety?" he writes.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct